The Pharmacology Center

Filter Your Results

 

News

 

FDA Approves Updated Safety Labeling Changes for Bivalirudin

April 15, 2016 -- The US Food and Drug Administration (FDA) issued safety labeling changes for bivalirudin (Angiomax, The Medicines Company) that were approved by the FDA Cent…

Early-BAMI Trial Fails to Meet Primary Endpoint

April 11, 2016 -- Findings from the Early-BAMI (Effect of Early Beta-blocker Administration Before Primary Percutaneous Coronary Intervention [PCI] in Patients with ST-Elevati…

HOPE-3 Study Supports Broader Use of Statins in Intermediate-Risk Populations

April 2, 2016 -- Three separate reports from the large HOPE-3 (Heart Outcomes Prevention Evaluation-3) trial were presented at ACC.16, the American College of Cardiology&rsquo…

GAUSS-3 Compares Evolocumab PCSK9 Inhibitor to Ezetimibe and Studies Muscle-Related Side Effects of Statins

April 3, 2016 -- The GAUSS-3 study was presented by Lead Investigator Steven Nissen, MD, at ACC.16, the American College of Cardiology’s 65th Annual Scientific Session h…

Effient for Certain ACS-PCI Patients With STEMI and NSTE-ACS Supported by DAPT Guideline Update

March 31, 2016 -- Daiichi Sankyo Company, Limited and Eli Lilly and Company announced that the new American College of Cardiology (ACC)/American Heart Association (AHA) guidel…

ACC/AHA Publish 2016 Focused Update of Guidelines for DAPT

March 31, 2016 -- The American College of Cardiology (ACC) and the American Heart Association (AHA) jointly released updated guidelines for dual-antiplatelet therapy (DAPT) in…

Amgen Wins Patent Case for Its Repatha PCSK9 Against Sanofi and Regeneron’s Praluent PCSK9

March 16, 2016 -- Amgen announced that a Delaware jury delivered a verdict in the company’s favor in a trial on the validity of two Amgen patents that describe and claim…

Meta-Analysis Evaluates Medicure’s Aggrastat for PCI Patients

February 23, 2016 -- Medicure Inc. announced the presentation of a study, “Comparison of High-Dose Bolus Tirofiban With Other Anticoagulation Strategies for Percutaneous…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.